Cellebrite DI Ltd. (CLBTW)
- Previous Close
5.94 - Open
5.70 - Bid --
- Ask --
- Day's Range
4.50 - 5.90 - 52 Week Range
4.50 - 5.90 - Volume
3,922 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 1.52
- PE Ratio (TTM)
93.72 - EPS (TTM)
0.06 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.
www.cellebrite.comRecent News: CLBTW
View MoreCompare To: CLBTW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLBTW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-28.51%
Return on Assets (ttm)
6.39%
Return on Equity (ttm)
--
Revenue (ttm)
362.49M
Net Income Avi to Common (ttm)
-103.33M
Diluted EPS (ttm)
0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
305.31M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
77.68M
Company Insights: CLBTW
CLBTW does not have Company Insights